Printer Friendly

Topical composition from Dr. Reddy's.

* US Patent No. 8,431,140 B2; Dr. Reddy's Laboratories, Inc., Bridgewater, NJ, and Reddy's Laboratories, Ltd., Hyderabad, India, have patented a single phase topical pharmaceutical composition. It contains a biologically active agent selected from the group consisting of terbinafine, naftifine, amorolfine, butenafine, derivatives thereof, salts thereof, or combinations thereof; a delivery vehicle comprising a non-polymeric crystallization inhibitor that is capable of delaying crystallization of the biologically active agent, and a film-former; a volatile solvent in an amount selected to create a subsaturated solution of said biologically active agent; and water. The biologically active agent attains a supersaturated state upon evaporation of the volatile solvent upon said administration.
COPYRIGHT 2013 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Patent Review
Publication:Household & Personal Products Industry
Date:Jun 1, 2013
Words:108
Previous Article:Galderma patents composition for keratinization disorders.
Next Article:Cosmetic preparations of lipid mixtures.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters